CizzaG, BrownRJ, RotherKI. Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest, 2012; 35: 541–46.
2.
ShoenleEJ, ShoenleD, MolinariL, LargoRH. Improved intellectual development in children with type 1 diabetes: association with HbA1c, age at diagnosis and sex. Diabetologia, 2002; 45: 108–14.
3.
RovetJ, EhrlichRM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr, 1999; 134: 503–6.
4.
DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. N Engl J Med, 1993; 329: 977–86.
5.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care, 1999; 22: 99–111.
6.
RauschJR, HoodKK, DelamaterA, Shroff PendleyJ, RohanJM, ReevesG, DolanL, DrotarD. Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes. Diabetes Care, 2012; 35: 1219–24.
7.
PihokerC, BadaruA, AndersonA, et al., for the SEARCH for Diabetes in Youth Study Group. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the search for diabetes in youth study. Diabetes Care, 2013; 36: 27–33.
8.
MaurasN, BeckR, XingD, et al.Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to10 years. Diabetes Care, 2012; 35: 204–10.
9.
LevetanC, WantLL, WeyerC, et al.Impact of pramlintide on glucose fluctuations and post-prandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care, 2003; 26: 1–8.
10.
RamanVS, MasonKJ, RodriguezLM, et al.The role of adjunctive exenatide therapy in pediatric type 1 diabetes. Diabetes Care, 2010; 33: 1294–96.
11.
SarkarG, AlattarM, BrownRJ, QuonMJ, HarlanDM, RotherKI. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care, 2014; 37: 666–70.
12.
Solis-HerreraC, TriplittC, Garduno-GarciaJ, AdamsJ, DeFronzoRA, CersosimoE. Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study. Diabetes Care, 2013; 36: 2756–62.
13.
MonnierL, LapinskiH, ColetteC. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemica of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care, 2003; 26: 881–85.
14.
BergenstalRM, TamborlaneWV, AhmannA, BuseJB, DaileyG, DavisSN, JoyceC, PeoplesT, PerkinsBA, WelshJB, WilliSM, WoodMA. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med, 2010; 363: 311–20.
15.
HovorkaR, ElleriD, ThabitH, AllenJM, LeelarathnaL, El-KhairiR, KumareswaranK, CaldwellK, CalhounP, KollmanC, MurphyHR, AceriniCL, WilinskaME, NodaleM, DungerDB. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care, 2014; 37: 1204–11.
16.
MaahsDM, CalhounP, BuckinghamBA, ChaseHP, HramiakI, LumJ, CameronF, BequetteWB, AyaT, PaulT, SloverR, WadwaRP, WilsonDM, KollmanC, BeckRW. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care, 2014; 37: 1885–91.
17.
BeckRW, RaghinaruD, WadwaRP, ChaseHP, MaahsDM, BuckinghamB. Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care, 2014; 37: 1224–29.
18.
WeinzimerSA, SteilGM, SwanKL, DziuraJ, KurtzN, TamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care, 2008; 31: 934–39.
19.
HovorkaR, AllenJM, ElleriD, et al.Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomized crossover trial. Lancet, 2010; 375: 743–51.
20.
KordonouriO, PankowskaE, RamiB, et al.Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia, 2010; 53: 2487–95.
21.
PinskerJE, NguyenC, YoungS, FrederciksGJ, ChanD. A pilot project for improving paediatric diabetes outcomes using website: the pediatric diabetes education portal. J Telemed Telecare, 2011; 17: 226–30.
22.
CadarioF, BinottiM, BrustiaM, et al.Telecare for teenagers with type 1 diabetes: a trial. Minerva Pediatr, 2007; 59: 299–305.
23.
LandauZ, Mazor-AronovitchK, BoazM, et al.The effectiveness of Internet-based blood glucose monitoring system on improving diabetes control in adolescents with type 1 diabetes. Pediatr Diabetes, 2012; 13: 203–20.
24.
MillerKM, BeckRW, BergenstalRM, GolandRS, HallerMJ, McGillJB, RodriguezH, SimmonsJH, HirschIB. T1D exchange clinic network evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care, 2013; 36: 2009–14.
